Resistance of livestock to viruses: mechanisms and strategies for genetic engineering by Gavora, JS
Review
Resistance of livestock to viruses:
mechanisms and strategies
for genetic engineering
JS Gavora
Centre for Food and Animal  Research, Agriculture and  Agri-Food Canada, Ottawa,
ON  KIA OC6 Canada
(Received 26 March 1996; accepted 13 August 1996)
Summary -  This communication  aims  to inform  readers from  research and  industry about
the possibilities of  developing  genetic engineering  strategies for improvement of  resistance
to viruses in  livestock.  It  briefly reviews coevolution of hosts and parasites,  principal
elements of virus-host  interactions,  existing  resistance  mechanisms, and conventional
methods  for improvement  of  disease resistance. Research  results from  genetic  engineering  of
new  resistance mechanisms  in both  plants and  animals, as well as investigation of  possible
risks and ’biological cost’ of such mechanisms are summarized as a background for the
discussion of prerequisites and strategies for future genetic engineering of resistance to
viruses in livestock. It is concluded  that, while conventional breeding methods  will remain
the principal approach to the improvement of disease resistance, in some instances the
introduction of new, genetically engineered resistance mechanisms may  be  justified.
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Résumé - Résistance des animaux de ferme aux  virus: mécanismes et stratégies de
génie génétique. Cette mise au point vise à informer les chercheurs et les professionnels
des possibilités  qu’offre  le  génie génétique pour améliorer  la  résistance  aux virus  des
animaux de ferme. Le rapport passe en revue la coévolution hôté-parasité,  les principau!
aspects des interactions virus-hôte, les mécanismes de résistance existants et les méthodes
classiques d’amélioration de la résistance avx maladies. Les résultats des recherches sur
la mise en ceuvré par génie génétique de nouveaux mécanismes de résistance tant animale
que végétale sont résumés, ainsi que l’étude des risques possibles et du « coût biologique»  »
de ces mécanismes.  Ces considérations constituent la toile  de fond de la  discussion sur
les  conditions requises  et  les  stratégies pour,  à l’avenir,  améliorer par génie génétique
la résistance aux virus chez les  animaux de ferme. La conclusion tirée  est  que,  à côté
des méthodes classiques de sélection qui resteront la principale voie d’amélioration, dans
certains cas  il peut être justifié d’introduire de nouveaux mécanismes de résistance par
génie génétique.
animal / virus / mécanisme de résistance / génie génétiqueINTRODUCTION
Maximum survival of livestock, with good health and well being are conditions
for  efficient  animal production. Many of the current livestock disease problems
that prevent the realization of this optimal production goal are caused by viruses,
described by  Peter Medawar  as &dquo;pieces of bad  news  wrapped  in protein  coat&dquo;.  This
review deals with possible new, genetic engineering strategies for the improvement
of resistance to viruses in livestock. Since work on genetic engineering of disease
resistance is more advanced in plants than in livestock, information on  research in
plants is also reviewed.
The use of livestock for food, fibre and draft over hundreds of years has led to
a significant influence by humans  on the evolution of domesticated animal species.
Some of the changes induced by artificial  selection parallel  in their significance
speciation. A  modern  meat-type  chicken can be  viewed  as a  species different from a
modern  egg-type  chicken. Similar differences exist between  breeds  of  dairy and  beef
cattle. This  ’genetic engineering’ of  livestock was  achieved  through  the  long-term  use
of conventional genetic improvement methods. It can be argued that gene transfer
represents  just another phase  in the development  of  genetic engineering of  livestock
and that it would be foolish not to take advantage of the new  technologies. Thus
introduction of new mechanisms of disease resistance in livestock by gene transfer
may  be viewed as a logical continuation of the creative influence of humans  on the
evolution of  farm  animals and  birds that could  benefit mankind  by  improvements  in
food safety and  production  efficiency. Increased disease resistance will also improve
the welfare of livestock.  The latter consequence may make this type of genetic
engineering more  acceptable to the general public than  other types of  gene  transfer.
If there is one attribute that is common  to viruses, it  is the lack of uniformity
in all aspects of their existence. Nevertheless, this review attempts to find general
elements and common patterns in the subject discussed. As background for the
discussion of the subject, the article deals briefly with coevolution of hosts and
parasites and principal elements of virus-host interactions, and reviews past im-
provement of disease resistance in plants and livestock by conventional breeding
and genetic engineering, as well as the potential ’biological cost’ of genetic manip-
ulation. It includes prerequisites for and principles of the design of new  resistance
mechanisms, and proposes possible strategies for the introduction of disease resis-
tance mechanisms by gene transfer.
The  main  goal  of  this review  is to inform  readers from  both  research and  industry
about  this area  of  long-term interest to animal agriculture and  outline the potential
use of the concept of new resistance mechanisms for the benefit of mankind and
improvement of animal welfare.
COEVOLUTION  OF  HOSTS AND  VIRUSES
Basic understanding of the parallel evolution of viruses and  their hosts provides a
useful starting point for the consideration of strategies for genetic engineering of
new  mechanisms of resistance. Therefore, principal elements of the coevolution of
viruses and hosts are briefly reviewed.Viruses are obligatory, intracellular parasistes with limited genome sizes that
code for  functions the virus cannot adopt from host cells  (Strauss et  al,  1991).
Viruses have their own  evolutionary histories, independent of those of their hosts.
It is not clear whether viruses had a single or multiple origin. The  origin of a  virus
is  defined as that time when its  replication and evolution became independent
of the macromolecules from which it  was derived  (Strauss et  al,  1991).  Viruses
may have arisen  (1)  by selection from an organelle;  (2)  from cellular DNA  or
RNA  components that donate macromolecules which gain the ability to replicate
and evolve  independently;  or  (3)  from  self-replicating  molecules.  Polymers  of
ribonucleotides  can contain  both the  information  required  and the  functional
capacity to form a self-replicating system (Watson et al,  1987).
The main mechanisms of viral  evolution  are  mutation,  recombination,  and
gene duplication.  Viruses have a very  short  generation  interval  and high mu-
tation  rate.  For  example,  the  mutation  rate  of  a  chicken  retrovirus  is  10- 5
nucleotide/replication cycles - approximately eight orders higher than that of the
host cell genome (Dougherty and Temin, 1988). Nevertheless, the virus always re-
tains its origin of  replication. Recombination  has also a large role in viral evolution
because it  allowed viruses to ’try out new gene combinations’. An  example of an
unusual acquisition of genes by  a  virus are three tRNA  genes in bacteriophage T4 -
a  type  of  gene  only observed  in eukaryotes (Gott et al, 1986). Although  it is possible
that the genes evolved within T4, the phage may  also have acquired the genes from
an eukaryotic host (Michel and Dujon, 1986). Similarly some retroviruses such as
Rous sarcoma  virus acquired oncogenes for their genome.
In general, DNA  viruses are more stable than RNA  viruses and do not cause
rapidly moving  pandemics as is the rule for RNA  viruses; in contrast, DNA  viruses
tend to  establish  persistent  or  latent  infections  which may lead  to  malignant
transformations (Strauss et  al,  1991). Exceptions to the general rule include the
herpesvirus of Marek’s disease, a DNA  virus that can cause rapidly moving  disease
outbreaks in chickens, and the avian leukosis viruses, RNA  viruses that exhibit a
period of latency and seldom cause high mortality.
A  disease of the host is not an evolutionary goal of the parasite. Compatibility
is  preferable to incompatibility. Subclinical infections are common; they are the
rule - diseases the exception. There  is no  selective advantage  to the  virus in making
the host ill,  unless the disease aids in the transmission of the virus to new  hosts,
such as in the case of diarrhea. In some instances, disease may also result from
an overzealous immune system. Hence the interplay between microbes and hosts
should not necessarily be seen as an ongoing battle but as a coevolution of species
(Pincus et al,  1992).
PRINCIPAL ELEMENTS  OF VIRUS-HOST INTERACTIONS
General considerations
Susceptibility (in the narrow  sense) is the  capacity  of  cells to become  infected. For  a
virus to survive and  reproduce, essential viral genes have to ensure: (1) replication
of  viral genomes  in which the involvement of  viral genes varies from assisting hostenzymes, to actually replicating the viral genome, although even the most self-
dependent viruses use some  host cell function in the process; (2) packaging of the
genome  into virus particle - viral proteins do  the packaging, although host proteins
may complex with viral ones in the process; and (3)  alteration of the structure
or function of the infected cell - the effects may range from cell  destruction to
subtle, but significant changes in function and  antigenic specificity of  infected cells.
In general, once  it enters, no  virus leaves a  cell unchanged.
During  their replication, viruses exploit host cell molecules at the expense of  the
cells. There are three types of viral infection (Knipe, 1991).  (1) In nonproductive
cases the infection is blocked because the cell lacks a component essential for viral
replication. The  viral genome  may  be  lost or remain  integrated in the host genome.
The  cell may or may  not survive or, if growth properties of  the cells are altered by
the  virus, oncogenic  transformation may  take  place. (2) Productive  infection  is when
the cell produces the virus but, as a consequence, dies and lyses.  (3) Productive
infection is when  the cell survives and continues to produce the virus.
The levels  of injury to the cells  resulting from viral  infection range from no
visible  effects to cell  death and include inclusion body or syncytium formation
and  cell lysis. In most instances cell injury is a consequence of processes necessary
for virus replication but at least in one known  instance, the penton protein of the
adenovirus, which  has  no  known  purpose  in the  viral cycle, causes cytopathic  effects
in monolayer cells (Valentine and Pereira, 1965).
Genetic engineering strategies that prevent entry of  viruses into host cells would
be effective against  all  three types of viral  infection.  Other strategies discussed
below can deal with various stages of  viral life cycles and would accordingly affect
the outcome  of  viral infection.
To provide a basis  for  the examination of the  opportunities  to  devise  and
genetically engineer new resistance mechanisms, the viral life  cycle that consists
of three fundamental steps,  attachment, penetration, and replication  (Roizman,
1991) will be examined in sequence.
Attachment of virus to the host cell
Attachment of the virus to the host cell  is,  in most instances, through a specific
binding of a virion protein, the antireceptor, to a constituent of the cell surface,
the receptor. Complex  viruses, such as vaccinia, may have more than one species
of antireceptor or antireceptors may have several domains, each reacting with a
different  receptor. Mutations of receptors may cause a loss of the capacity of a
receptor and antireceptor to interact and thus lead to resistance to viral infection.
It seems likely that mutations in antireceptors preventing viral attachment will be
automatically eliminated from  viral evolution, unless they are able to interact with
a substitute host.
The number of  receptors  for  which information  is  accumulating  is  rapidly
increasing. Examples  in table  I show  that receptors are mostly  glycoproteins. Not  all
cells in a  susceptible organism  express  viral receptors, a phenomenon  that may  limit
susceptibility. Even  though  our understanding  of  receptors is still at an  early stage,
it is obvious that viral receptors are molecules that have a normal physiological
function in the host.While  there  is a  great deal  of  variability  in  the  types  of  molecule  in viral receptors,
some  cell surface molecules are used by  multiple, often unrelated viruses (table I).
When viewed across host species,  for example, histocompatibility molecules are
receptors for  both Semliki-Forest togavirus and human coronavirus;  sialic  acid
residues  serve  as receptors  for both  the  influenza  myxovirus  and  reoviruses, although
there are rotaviruses that do not require their presence (Mendez et al,  1993) and
low  density lipoproteins (LDL)  are  receptors  for both  the human  minor  cold picorna
virus and avian leukosis viruses.
Viruses compete with molecules that require receptors for a physiological func-
tion of the host. For example, LDL  and the human  minor rhinovirus compete for
LDL  receptors (table I),  and cells with down-regulated LDL  receptor expression
yield much  less virus than  up-regulated  cells (Hofer et al, 1994). Viruses  tend  to use
abundant molecules as receptors, so that reduction in availability of the molecules
for  the physiological function is  not lethal,  or molecules whose function can be
substituted by other molecules. There are alternative viral strategies to deal with
the receptor problem. The  part of the sodium-independent transporter of cationic
amino acids, used as the receptor for ecotropic bovine leukemia virus (table I),  is
different from the part of  the protein directly involved in the amino-acid transport
function. Thus  the physiological function  of  the  receptor can  continue, despite bind-
ing of virus to the receptor (Wang  et al,  1994). Another example confirming this
possibility is the sodium-dependent transporter of inorganic phosphate  that serves
as the receptor for the gibbon ape leukemia virus (table I). Productive infection of
cells expressing  this receptor  results in complete  blockage  of  the uptake  of  inorganic
phosphate mediated by the receptor. Nevertheless, the infection is  not cytotoxic.
Hence, there is likely more  than one phosphate transport mechanism  in these cells
(Olah  et al, 1994). This aspect of  viral strategies may  open up  possibilities to block
the receptor sites, thus preventing entry of a virus without serious impairment of
physiological function of the receptor.
The  receptor for herpes simplex virus exemplifies a situation of special interest
from  the point of  view  of  future engineering  of  disease resistance. The  viral receptor
heparan sulfate is present on  cell surfaces but body  fluids also contain heparin and
heparin-binding proteins, either of which can prevent binding of herpes simplex
virus to cells  (Spear et  al,  1992). Hence spread of the virus  is  likely influenced
by both immune response and the probability that the virus will be entrapped
and inhibited from binding to cells by extracellular forms of the receptor (heparin
or heparan sulfate).  Similarly, soluble molecules of the CD4  receptor for human
immunodeficiency  virus, as  well as fragments  of  the  critical CD4  domains  can  inhibit
infection (Smith  et al, 1987). It has been  suggested  that a  secreted  receptor  for avian
leukosis virus might similarly be able to neutralize the virus (Bates et al,  1993).
Penetration of a virus into the cell
Penetration of a virus into the cells  is  usually an energy-dependent process that
occurs almost  instantly  after  attachment.  As summarized by Roizman (1991),
penetration can occur as  (1)  translocation of the entire virus particle across the
cell  membrane;  (2)  endocytosis resulting  in  accumulation of virus particles  in-side cytoplasmatic vacuoles; or  (3)  fusion of the cell  membrane with the virion
envelope. Non-enveloped viruses penetrate host  cells by the first  two processes.
Uncoating  of  the virus particle takes place after penetration. For some  viruses, such
as orthomyxoviruses and picorna viruses, divestiture of the protective envelope or
capsid takes place upon their entry into cells.  For others, such as herpes viruses,
the capsid is  transported along the cytoplasmic cytoskeleton into nuclear pores.
With reoviruses, only a portion of the capsid is  removed and the viral genome
expresses all  its  functions even though it  is  never fully released from the capsid.
While several genetic engineering strategies to prevent attachment of viruses to
host cells can be devised and  are proposed below, strategies to prevent penetration
of viruses attached to cells are much  less obvious.
Virus multiplication
Viruses  use many  strategies for replication leading  to (1) encoding and  organization
of viral genomes, (2) expression of viral genes,  (3)  replication of viral genes, and
(4) assembly and maturation of viral progeny. The  key event in these processes is
the synthesis of  viral proteins. Regardless of its size, organization, or composition,
a virus must present to the cell’s protein synthesizing mechanisms an mRNA  that
the cell recognizes and  translates.
The interaction between the viral cell attachment protein and host-cell recep-
tors is the principal determinant of tropism, but there are other factors involved.
For retroviruses and papovaviruses, cis-acting elements of the viral genome, gene
enhancers, which  are usually 50-100  bp  in size and  often repeated  in tandem,  stimu-
late transcription (Serfling et al,  1985). They  may  serve as an  entry point for RNA
polymerase II.  Enhancers may be both cell-type-specific and cell-differentiation-
specific, in that they function mainly  in certain cell types (Tyler and  Fields, 1991).
For avian retroviruses, enhancer regions within the long terminal repeat (LTR) are
an element of the viral genome that determines cell tropism of disease expression
(Brown  et al,  1988).
The cell imposes three constraints on the virus at the point of virus multipli-
cation.  (1)  The cell may lack enzymes to synthesize mRNA  off the viral RNA
genome, or may lack enzymes to transcribe viral DNA. (2)  Eukaryotic host cell
protein-synthesis machinery translates only monocistronic messages and does not
recognize internal initiation sites within mRNA.  As a consequence the virus must
synthesize either a separate mRNA  for each gene or an mRNA  encompassing a
’polyprotein’ to be later cleaved. (3) The  expression of viral proteins is  in compe-
tition with cellular genes. Viruses evolved strategies that either confer competitive
advantage to viral mRNA  or abolish translation of cellular mRNAs.
The host range of a virus defines both the kinds of tissue or cells and animal
species in which a virus can enter and multiply (Roizman, 1991). Receptors may
be species specific. For example, the poliovirus receptor is only found on primate
mammalian cells  (McLaren et  al,  1959). A  tissue-specific receptor is  exemplified
by the CD4  receptor for the HIV  virus, which is  present only on T-lymphocytes
(table  I).  Species-specifity  of receptors  is  one  of the  components of non-host
resistance that will be discussed in more  detail below.Other  virus&mdash;cell interactions
Infection with some viruses leads to inhibition of transcription of cellular protein-
coding genes by  host polymerase  II, possibly through competition  for transcription
between cellular and viral genes. Herpes simplex virions contain a transcriptional
activator  complex  (Post  et  al,  1981),  while adenovirus provides a  trans-acting
EIA  gene product responsible for increased polymerase activity after adenovirus
infection  (Nevins,  1986).  Viruses can also induce or express new DNA-binding
proteins. Thus  a  retrovirus encodes a homolog  to cellular transcription factor AP-1
(Bohmann  et al,  1987).
Splicing of  viral mRNA  precursors  is accomplished  by  cellular enzymes. Influenza
and retroviruses can regulate the extent of the splicing, adenovirus inhibits matu-
ration of cellular mRNA,  and influenza virus transcription complexes intervene in
the host mRNA  maturation (Knipe, 1991).
Many  viral mRNAs  are capped, in that they  contain a  single major  initiation site
near their 5’ end, and their translation is similar to that of host mRNA.  However,
inhibition of host mRNA  translation provides the virus with increased availability
of ribosomal units. Thus herpes simplex and poxvirus degrade cellular mRNA  to
decrease its translation (Inglis,  1982; Fenwick and McMenamin, 1984).
Other mechanisms include competition for the host translational apparatus by
production of large amounts of viral mRNA,  or viral mRNA  with higher affinity
to ribosomes than cellular mRNA  (Knipe, 1991) and changes in the specificity of
host translational apparatus; for example, extracts from poliovirus-infected cells
translate poliovirus but not host mRNA  (Rose et al,  1978).
Both RNA  and DNA  viruses cause  inhibition of  host-cell DNA  synthesis (Knipe,
1991). Eukaryotic cell proteins contain signals that target them to a specific cell
compartment or organelle. Viral proteins may  also contain similar signals for their
localization within  the  cell. Viral proteins make  use  of  cellular chaperone  proteins  to
secure  their proper  folding. Similarly, many  post-translational modifications of  viral
proteins are performed by cellular enzymes. For example, tissue-specific proteases
cleave  specific  proteins on the virion surface  thus  facilitating  virion  infectivity
(Scheid and Choppin, 1988).
Maintenance of  viral DNA  in the host cell and  release of  progeny  virus
There are two types of mechanism for maintaining viral DNA  in the host cell:  (1)
virus DNA  is integrated into the cellular genome, eg, in retroviruses; or (2) viral
DNA  is maintained as extrachromosomal circular molecule in the infected cell, eg,
Epstein-Barr virus,  or bovine papilloma virus.  Viruses that persist  in the body
may cause damage, and prevention of persistence may be the next best defence
if prevention of virus entry is  impossible. Persistence is  usually in differentiated
cells that remain morphologically unchanged but may  lose their differentiated or
’luxury’  function, as well as their homeostasis. Persistent viruses can negatively
influence host cells in two ways: (1) virus presence and replication causes damage
resulting in a selective disadvantage; and (2) in such a way  that the virus will gain
an evolutionary advantage for which there will be selection pressure to maintain.
Alternatively, some  viruses undergo a latency stage in their life cycle that seems to
cause little damage.Enveloped  viruses move  from  infected  cells either by  budding  through  the plasma
membrane or by secretion vesicles  containing virus  particles  within the plasma
membrane  (Knipe, 1991). Non-enveloped  viruses are mostly released by  lysis of  the
cells but they can also leave without cell lysis as in Simian virus 40 (Norkin and
Ouelette, 1976).
Spread of  virus through the host body
To facilitate  their survival and spread throughout the body, some viruses have
evolved strategies to modulate the immune response of their host to their favor,
a phenomenon recently reviewed by Fujinami (1994). Virus infection can lead to
development of immune responses against the host’s own  tissues and viruses can
also code for  proteins,  homologous to  cellular  proteins,  that modify the host’s
immune response.  For example, Epstein-Barr virus produces a BCRF1 protein
similar to the interleukin IL-10 protein (a cytokine-inhibiting factor) that inhibits
the production of IL-2 and IL-3,  tumor necrosis  factor, gamma interferon,  and
macrophage-granulocyte  colony-stimulating  factor.  The herpes  simplex  virus-1
(HSV-1) but not HSV-2 can interfere with the complement system by producing
a protein that acts as a receptor for the component of the complement cascade.
Virus  infections can  also interfere directly with  the major  histocompatibility system
(MHC). Cytomegalovirus encodes an MHC  class I heavy-chain homolog  that limits
expression of the cellular class I  molecules on cell surfaces and this may reduce
killing of infected cells by host defences.
EXISTING  RESISTANCE  MECHANISMS
Non-host resistance
Most animal and plant species are resistant to the great majority of  viruses. Non-
host resistance is the rule, susceptibility the exception. However, the nature  of  non-
host resistance is not sufficiently understood to fully explore the incompatibility
between viruses  and non-hosts  (Wilson,  1993).  Nevertheless,  it  is  certain  that
we,  as well  as  all  animals,  are  &dquo;continuously  bathed in  a sea of microbes,  yet
harmed by a relatively few&dquo;  (Oldstone, 1993). To coexist, viruses and their hosts
have established, to a greater or lesser degree, an equilibrium. In general, normal
coevolution of parasites and  their hosts is from disoperation, through exploitation,
to toleration and  from  facultative to obligatory mutualism, but genetic changes may
also bring  reversals to  this process (Dobzhansky, 1959). None  of  the  strategies for the
creation of  new, genetically engineered  viral resistance mechanisms  proposed  in this
article are derived from non-host resistance. Nevertheless, a brief discussion of the
subject is included to stimulate further exploration of  this widespread phenomenon
as the possible basis for protection of livestock against viruses.
Some knowledge of non-host resistance mechanisms is  emerging from experi-
mentation with plant viruses that infect permissible but normally  resistant cells by
bypassing the resistance barrier (Dawson and  Hilf, 1992). Viral host range  is deter-
mined by interactions between existing viral gene products and corresponding host
components. Because  of  the obligately parasitic nature  of  viruses, viral host range  isnot determined  by  a  particular gene  product  that enables  the  virus to overcome  host
defences but by a  ’fit’ between  viral gene product and  certain gene products of the
host. There  are two  general prerequisites for successful infection: (1) Presence  of  all
conditions necessary  for viral infection. Absence  of  the conditions results in ’passive
resistance mechanisms’ in plants, that tend to be recessive or incompletely dom-
inant.  (2) Absence of successful host defences. Adaptation mechanisms of viruses
that enable them  to infect potential hosts protected by non-host mechanisms may
include an ability to overcome a host block by a mutation or recombination with
another virus, or acquisition by the virus of capabilities formerly provided by the
hosts that are not available in resistant plants. A  virus can capture such genetic
information from the host.
Non-immune  mechanisms
There are many mechanisms of resistance  to  viral  diseases.  For our purposes,
emphasis will be placed on non-immune  mechanisms. Of  particular interest in this
review are those mechanisms  that prevent the entry of  viruses into host cells. Viral
receptors can  be  variable  so  that some  alleles of  the  receptor may  make  the  potential
host resistant to  viral infection. However,  it is only  rarely  that  resistance  to  infection
is observed in otherwise susceptible host species. This indicates that during virus-
host coevolution, viruses tend  to utilize evolutionarily stable molecules  as receptors.
Resistance to infection by parvovirus B 19 in some humans  is due to lack of a
specific virus receptor. People  who  do  not have  the  erythrocyte P  antigen  parvovirus
receptor (Brown et  al,  1993)  are naturally resistant  to the virus  (Brown et  al,
1994). Another  example  is resistance to coronaviruses  in mice. A  monomeric  protein
has been identified as a receptor for mouse hepatitis virus on intestinal and liver
cells.  The presence of this  receptor appears to be the principal determinant of
susceptibility to infection (Boyle et al,  1987). Similar variation in viral receptors is
observed in genetic resistance to avian leukosis virus (ALV) infection in chickens
(Payne,  1985).  The ALV  receptors, which belong to the family of receptors for
LDL  (Bates et al,  1993), include recessive alleles that do not allow viral entry into
potential host cells and render some chickens resistant to the virus. The receptor
for subgroup A  ALV  was shown  to map  to TVA * S  known  as the dominant gene for
susceptibility to subgroup A  virus (Bates et al,  1994).
Susceptibility of  cells to infection needs to be  distinguished from  permissiveness,
which  can  be  defined as the  ability of  a  cell to support  viral replication. For  example,
chick cells  are not susceptible to poliovirus but are permissive to its  replication
following their transfection with poliovirus RNA  (Roizman, 1991). Such cells are
potential hosts for a virus, providing a mutation provides means for the virus to
enter the cells.
In laboratory mice, alleles at the Fv-4  locus determine  susceptibility to infection
with ecotropic murine leukemia viruses and the resistance is dominant in hetero-
zygous mice (Ikeda and Odaka, 1983). A  viral protein gp70  normally  interacts with
the viral receptors on  cells. However, in resistant mice, the specific receptor on  cell
membranes seems already bound by the gp70 whose production is  controlled by
the mouse  FV-4’’ resistant allele. This system is similar to that in chickens, where
the endogenous retroviral gene ev-6, expressing the subgroup E  endogenous viralenvelope also controls resistance to infection by subgroup E  virus (Robinson et al,
1981).
Resistance of mice to  certain  strains  of influenza virus  is  a dominant trait
associated  with  the  allele Mx  on  chromosome  16 (Staehli et al, 1986). The  resistance
is  mediated by action  of alpha-  and  beta-interferons  that  induce Mx protein
expression which  inhibits synthesis of viral mRNA  (Krug  et al,  1985).
A recent  review  of natural,  ’preimmune’  resistance  loci  in  mice  (Malo and
Skamene, 1994) includes genes  controlling resistance to influenza  virus, cytomegalo-
virus,  ecromelia, Friend leukemia virus,  mink cell  focus-forming virus,  Moloney
leukemia, radiation leukemia, and Rous  sarcoma  virus. The  resistance genes repre-
sent a variety of mechanisms that do not involve viral receptors. For example, the
Cmvl  gene, associated with resistance to cytomegalovirus, appears to control host
responses mediated by  natural  killer and  inflammatory  response  cells. Similarly, the
resistance loci in Friend leukemia control the susceptibility of target cells to viral
replication.
Immune  mechanisms
It  is  not  the purpose of this  review to  provide a detailed  account of immune
mechanisms that protect against virus  infection.  The brief text below will  give
only a general outline of immune  responses and examples of how  the system may
be influenced by  viruses.
Acquired immune responses  involve  phagocytic,  humoral and cell-mediated
systems. Only  the  cell-mediated immune  response  that is especially effective against
cells  containing actively replicating virus and, as a rule,  is  the most important
defence  against  viral  infections  will  be discussed  briefly.  The cellular  immune
system becomes sensitized to viral infection only after viral proteins are degraded
to short linear peptide epitopes that become complexed with class I  or II major
histocompatibility complex proteins. The resulting complexes are transported to
cell surface, where they are presented as ’non-self’  entities to T-lymphocytes. If
the viral antigen has not previously encountered the T-cell repertoire of the host,
the initial  antigen-specific activation event requires appearance of MHC-peptide
complexes on  antigen-presenting  cells. But  if activated T-cells, previously  sensitized
to the viral epitopes are available, then a broader class of antigen-presenting cells
can be targeted for clearance by cytotoxic T  cells.  In both events, the ability to
discriminate self molecules from the viral epitopes depends on the presentation
of the non-self peptide to T-cells in specific peptide-binding grooves of the MHC
molecules on antigen-presenting cells.
McFadden  and  Kane  (1994) summarized  how  DNA  viruses perturb  the MHC  and
alter immune recognition. A  number of gene products of DNA  viruses have been
identified as directly affecting MHC  expression or antigen presentation, whereas
RNA  viruses interact with MHC  by indirect mechanisms. Most DNA  viruses are
able to modulate  cellular immunity. It seems  that many  viral gene products remain
to be identified among  the open reading frames of as yet unknown function that
exists  in  these  viruses.  Besides  a trivial  strategy  of hiding DNA molecules  in
cells, such as neurons that lack MHC  surface molecules, viruses can modify MHC
expression directly within cells  or indirectly at the level  of cytokine regulation.There is now evidence that viruses can combat antiviral effector T  cells directly
by blocking their antiviral  activity  (Bertoletti  et  al,  1994).  In humans infected
with  HIV-1  and hepatitis  B viruses,  naturally  occurring  variants  of  epitopes
recognized by cytotoxic T  lymphocytes may act  as antagonists in vivo because
the corresponding peptides prevent a cytotoxic T  cell response. Although exactly
how  the antagonists function is not known, it is evident that the presence of these
antagonists prevents the T  cell from performing its function.
Endogenous viruses  represent  a separate  phenomenon with  regards  to  the
immune system. As a rule,  the host  is  completely immunologically tolerant  to
endogenous viruses.  However,  antibodies  against  endogenous retroviruses  were
found in mice (Miyazawa et al,  1987). How  the immune system makes antibodies
against endogenous retroviral gene products  is unknown  but this ability may  relate
to the expression of such genes after the establishment of immunological tolerance
to endogenous retroviral antigens expressed earlier in life (Miyazawa and  Fujisawa,
1994). A  similar delay in expression of the endogenous viral gene ev-6 has been
described in chickens (Crittenden, 1991) and  may  serve as a model  for construction
of similar ’self-vaccinating’ transgenes in the future.
Pathogen-mediated resistance
Given the potential benefits that can be derived from the use by the host of parts
of a pathogen’s genome to induce resistance,  the paucity of pathogen-mediated
resistance mechanisms in  nature is  surprising.  The situation begs the question
whether evolution  exhausted  all  such  possibilities  in  the  development of host
defences. Why  did certain mechanisms develop and others not? A  reason for the
absence or rare occurrence of pathogen-mediated defence mechanisms may  be that
they encompass some  disadvantage for the host.
One example in which a viral genome has become an integral part of the host
are endogenous proviruses found in germ cells  of all  vertebrates.  For example,
in the laboratory mouse endogenous proviruses occupy more than 0.5% of the
cellular DNA  (Pincus et  al,  1992). In the genomes of chickens, there are several
families of retrovirus-related permanent insertions. In the most thoroughly studied
family of endogenous viral genes, there are more than 20 endogenous proviruses
in various parts of the genome (Crittenden, 1991). The presence of some of these
proviruses may  interfere in the spread of the generally non-pathogenic endogenous
virus produced by other such proviruses. However, the endogenous proviruses do
not protect the host against infection with similar but more harmful, pathogenic
exogenous viruses. On  the contrary, the antigenic similarity between the products
of  the endogenous  proviruses and  the exogenous  viral antigens reduces the ability of
birds with certain types of these proviruses to mount an immune  response against
the exogenous  virus (Crittenden et al, 1984; Gavora  et al, 1995b). A  possible reason
why  other endogenous proviral sequences did not evolve as resistance mechanisms
is that their expression may adversely affect important physiological processes of
the host (Gavora et  al,  1995a,b) and reduce the ability of the host to resist the
exogenous analogues of the proviruses.CONVENTIONAL  METHODS  FOR  IMPROVEMENT  OF
RESISTANCE AND  POSSIBLE ADVANTAGES OF GENETICALLY
ENGINEERED  RESISTANCE  MECHANISMS
Genetic variation  is  a prime prerequisite  for  genetic change by selection.  As a
general rule, genetic variation exists in the ability of  livestock to tolerate infectious
diseases. And  it  was this variation that allowed populations of domestic animals
and  birds to survive under continuous exposure to rapidly evolving disease agents.
Before domestication, disease resistance of today’s livestock species was influenced
by  natural selection and  the current status of  variable resistance to multiple disease
agents can be considered to be the result of a response to the selection pressure of
multiple pathogens.
As a consequence of domestication, a significant new element that entered this
evolutionary system was artificial selection for characters that benefit humans as
users of livestock.  Simultaneously, housing conditions evolved towards increased
concentration of animals and birds and thus provided opportunities for spread of
pathogens. Improved disease prevention and control measures now provide some
compensation  for the larger population sizes used in current production systems.
Selection for disease resistance plays a relatively minor but increasingly impor-
tant role in livestock improvement. The  choice  of  selection criteria and  the emphasis
they  receive in the  context of  total selection pressure available to a  practical breeder
are decided by market demands and economic considerations. Disease resistance
traits receive attention from  the breeders mainly when  a specific disease is a major
cause of economic  loss.
Although  in most  instances existing genetic variation provides an  adequate  basis
for resistance selection,  selection may not always be practised. Such selection is
expensive because the expression of resistance traits requires exposure of selection
candidates or their relatives to the disease agent. This is why  industries prefer to
look  for indirect selection techniques  that do  not  require pathogen  challenge. Recent
developments  in gene mapping  provide good  prospects  for progress in this direction.
Indirect selection for resistance to the herpesvirus of Marek’s disease in chickens,
by increasing the frequency of the ’resistant’ major histocompatibility haplotypes,
is one example of such a technique. It has been practised by most of the world’s
poultry breeding companies over the past two decades (Gavora, 1990).
Conventional procedures for direct and indirect selection for disease resistance
will in the foreseeable future be the main  route for genetic improvement of disease
resistance. One disadvantage of their application is the general absence, with rare
exceptions mentioned above, of genetic variation in resistance to infection. Thus
genetic improvements in  disease  resistance  by conventional means lead mostly
to better resistance of livestock to disease development - a situation where the
organism becomes infected but tolerates the pathogen and reduces its ill  effects.
Hence development of new  genetic mechanisms  that prevent entry of a pathogen
into  the  host,  or  otherwise  substantially  improve the  position  of the  host  in
the pathogen-host interaction  is  justified.  While conventional selection leads to
quantitative improvement of resistance,  the new mechanisms would represent a
qualitative change that, at least in some  instances, will justify the large effort and
cost. The  expenses  will be  further  justified if the new, engineered mechanism  provesto be stable and remains effective despite evolution of the pathogen and functions
without harmful effects on the animal’s production capacity. Improvement in the
welfare of the modified livestock will be an automatic, additional benefit.
In crops
Despite large differences between animals and plants,  sufficient  similarities exist
in their resistance mechanisms to justify examination of the situation in plants
with regards to genetic engineering of viral resistance. For example, normal virus
replication requires a subtle balance of virus and host coded proteins, present in
critical relative concentrations at specific times and locations. Therefore, Wilson
(1993)  suggests that any unregulated superimposition of protein or nucleic acid
species  interacting with the virus can result  in  plants  in an apparently virus-
resistant phenotype. The  results from  experimentation with animal  cells into which
a  viral gene was  inserted indicate that a similar situation may  also exist in animals
(Gavora  et al,  1994).
The idea that viral components contained in plants might interfere with virus
infection was  first proposed well before gene transfer techniques became available
(Hamilton,  1980)  and the concept of pathogen-derived resistance was first  put
forward in a formal statement by Sanford and Johnston (1985). There are several
approaches to the introduction of disease resistance by gene transfer  in  plants
(Fitchen and Beachy,  1993). They include transfers of segments of viral genome
encoding capsid or coat proteins, viral sequences encoding proteins that may be
subunits  of  viral replicase, sequences incapable  of  encoding  proteins, entire genomes
of defective, interfering viruses, and complete genomes of mild virus strains. The
transgenes may  act on  initiation of  infection, replication of  virus, spread  of  infection
throughout the plant, and symptom  development. The  level of protection derived
from  the  transgene ranges from  low  to high  and  its breadth  of  host range  from  broad
to narrow. The available data are not sufficient to firmly establish the molecular
mechanisms of the protection.  In general, although a viral sequence may confer
resistance in one virus-host system, an analogous sequence from a different virus
in another virus-host system may  not be  effective.
Protection conferred by sequences encoding viral coat proteins
The conceptual  simplicity  of the approach and availability  of virus  coat  gene
sequences facilitated broad implementation of this strategy. Fichten and Beachy
(1993)  list  19 published examples of this  approach.  It  is  unlikely that a single
mechanism accounts  for  the  observed  resistance  of  the  transgenic  plants  but
regardless of the mode of the transgene action,  resistance  results from a block
in an  early event in the infection process (Fichten and Beachy, 1993). In resistance
to some  viruses other than tobacco mosaic, it seems that accumulation of the coat
protein transgene RNA, rather than the virus coat protein itself is  responsible
for  resistance.  Resistance has been observed even in  plants  that  transcribed a
translation-incompetent coat protein mRNA  (Kawchuk  et al,  1991; De  Haan  et al,
1992).  It seems that even in the absence of understanding of its mechanism, the
strategy can be extended to other plant species and viruses.Protection by sequences encoding replicase-related proteins
Replicase-mediated resistance was  first demonstrated against tobacco mosaic virus
(Golemboski et al,  1990). The number of initially infected cells in transgenic and
non-transgenic plants was the same but virus replication was markedly reduced in
cells of the transgenic plants. Replication of the virus was severely impeded and
little or no systemic spread of  the virus occurred (Carr and Zaitlin, 1991).
Protection by the accumulation of RNA
Plants were protected by RNA-mediated resistance  to  a degree comparable to
protein-mediated resistance. Transgenic tobacco plants, carrying a translationally
defective tomato spotted wilt virus nucleocapsid gene exhibited resistance similar
to that in experiments with translationally competent gene constructs (De Haan
et al,  1992). Other examples include potato plants with constructs producing  sense
and  antisense transcripts of  potato  leafroll virus (Kawchuk  et al, 1991) and  tobacco
plants and similar transcripts of tobacco mosaic virus (Powell et al,  1989).
Protection by transgene copies of mild strains,  satellites and satellite
RNAs, and defective interfering viruses
Transgenic tobacco plants carrying cDNA  of a mild strain of tobacco mosaic virus
developed only mild symptoms when challenged with severe strains of the virus
(Yamaya  et al,  1988). Transgenic plants expressing cloned copies of different virus
satellites or satellite RNAs  have also been produced. For example, in experiments
with tobacco ringspot virus, such transgenic plants exhibited delayed development
of symptoms (Gerlach et  al,  1987).  Nevertheless,  this approach does not seem
desirable because the transgenes may  produce active pathogens by recombination
or a pathogenic mixture. Also, transgene components may  recombine with another
virus, thus extending its host range or virulence (Fitchen and Beachy, 1993).
The identification of a variety of disease resistance  (R) genes is  expected to
facilitate identification and introgression of new resistance from wild species into
new  plant varieties. It  is well known that a new resistant plant variety developed
over a long time and with great effort is often overcome by a new  pathogenic race
-  an  immensely  wasteful situation. Such breakdown  of  resistance  is much  less likely
in varietal mixtures  that carry an  array of  different R  genes. Once  different R  genes
are cloned, varieties can be produced  that consist of mixtures of  lines differing only
in the R  gene allele they carry (Staskawitz et al,  1995). For genetically engineered
resistance, pathogen-inducible promoters, such as the prpl-I promoter in potato
(Martini et al, 1993) may  be the most advantageous as they induce the ’resistance’
peptide(s) only in cells that are being challenged by a compatible pathogen (De
Wit, 1992).
In livestock
The  extent of the research  effort to genetically engineer new  resistance mechanisms
in animals is much smaller than that in plants and available data on the subject
are reviewed below.Pathogen-mediated resistance
The first  successful  introduction of pathogen-mediated resistance  to  disease  in
animals was  reported by  Salter and  Crittenden (1989). They  produced  several lines
of chickens, each with an insert of a recombinant avian leukosis retroviral genome
at a different locus within the host genome. The transgenic birds that expressed
only the viral envelope coding region of the recombinant genome were shown to
be resistant to the corresponding subgroup of the avian leukosis virus (Salter and
Crittenden, 1989; Gavora  et al,  1995a), due  to a blockage of  virus receptors by the
viral envelope proteins.
Another introduction of a new  virus resistance mechanism into a livestock host
was attempted by Clements  et al (1994). They  produced sheep carrying transgenes
expressing the envelope genes of visna virus, under the control of the visna virus
LTR. Visna virus  is  a prototype of a family  of ovine  lentiviruses  that  cause
encephalitis, pneumonia, and  arthritis in sheep  worldwide. In  three  transgenic  lambs
that expressed the visna  virus envelope  glycoproteins, the transgene had  no  obvious
deleterious effect.
Inhibition of virus replication in mammalian cells  has been demonstrated in
humans  with wild-type (Tsunetsugu-Yakota  et al,  1992) and mutant (Owens  et al,
1991; Hope et  al,  1992) forms of replication-associated proteins encoded by HIV
and adeno-associated viruses.  The mutated trans-dominant forms of the adeno-
associated  virus Rep78  protein  bind  to the  origin  of  viral replication, thus  preventing
the  binding  of wild-type  protein, while  trans-dominant  mutant  forms  of  the HIV  Rev
protein associated with the wild-type Rev protein, form nonfunctional complexes
(Owens  et al,  1991).
Expression under the control of metallothionein of a single glycoprotein D  gene
from herpes simplex  virus (HSV-1) rendered  cells resistant to infection by HSV  but
not by other viruses (Johnson and Spear, 1989). The mechanism  of  this resistance
is not known but it  seems likely that D  interacts with a cell surface component
required for viral penetration.
In  an  attempt  to introduce  resistance  to bovine  rotavirus that causes  calf  diarrhea
and results  in  large economic losses,  two genes that  code for  rotavirus  capsid
proteins, implicated in early virus-host cell interactions, were transferred into the
genomes of susceptible cells  in culture and, one of the genes,  also into genomes
of laboratory mice (Gavora et  al,  1994). The transgenes produced mRNA  of the
relevant viral genes but no  corresponding  protein was detected either in the cells or
in the mice. Nevertheless, several of the transformed cell lines showed significantly
increased resistance to bovine rotavirus (Gavora et  al,  1994), while no increase
in the resistance of four similarly transformed lines of mice was detected following
challenge  of  pups  shortly after birth with  the  virus (JS Gavora,  unpublished  results).
Antisense RNA
Although not  yet  tested  in  vivo,  the use  of antisense RNA  to combat viruses
has received attention by researchers and presents another possible avenue for the
construction of new  resistance mechanisms. The  possibilities of  inhibiting retroviral
replication by  antisense molecules before  its integration into a  host chromosome  hasbeen demonstrated (To and Neiman, 1992). To block viral integration, antisense
sequences can be designed to target regions essential in the synthesis of  viral DNA
intermediates or viral integration. Replication of a recombinant avian retrovirus,
carrying a neomycin resistance gene neo’ in the antisense orientation was blocked
when  cells expressed high levels of neo’ RNA  molecules in the sense orientation,
suggesting that antisense RNA  inhibition may be a useful strategy for inhibition
of retroviral infections (To et al,  1986). It was hypothesized that when sequences
immediately  upstream  of  the  polypurine  tract are hybridized  to antisense molecules,
RNase H failed  to  process the RNA sequences  in  the polypurine tract  into  a
functional primer for the synthesis of plus-strand DNA  (To and Neiman, 1992).
They suggested that an antisense segment in that region can be defined for use
in a large number of pathogenic retroviruses. These experiments also showed that
constructs  expressing  the  antisense RNAs  can  be  delivered by  replication-competent
retroviral vectors to host cells in culture, thereby immunizing  the host cells against
superinfection with different retroviruses.
The advantage of the antisense RNA approach may be that  only about  15
basepairs are needed  to bind  the antisense RNA  with absolute precision to a  unique
mRNA  and intensive research is now  under way  to develop antisense therapeutics
(Bradley et al,  1992). Even  though  the mechanism  will not prevent viral entry into
host cells,  it may  prevent integration of the viral genome  in the host chromosome.
Catalytic RNAs,  known  as ribozymes, are not rare in nature and  it is possible to
engineer an  intron that can  repeatedly perform  the  first chemical  step  in the  splicing
process (Parker et al, 1992). Ribozymes  have been shown  to cleave target RNA  and
to inhibit mRNA  transcript activity (Edington and Nelson, 1992). The principal
advantage  of  ribozymes  is their ability to cleave and  thus  inactivate multiple  targets.
Even though ribozyme-mediated gene  inhibition  involves  a mechanism  (target
cleavage)  different from that of bacterial antisense RNAs, many of the essential
steps of the two mechanisms are identical. Ribozymes were shown to successfully
inhibit gene expression in Xenop!s  oocytes in tissue culture (Cotten and  Birnstiel,
1989) and may be another possible approach to the engineering of new disease
resistance mechanisms  for livestock.
Transfer of resistance genes from another species
As  was  mentioned  above, the  murine  Mxl  is a  protein with  activity against influenza
virus. Garber  et al (1991) inserted cDNA  encoding  this protein into chicken embryo
fibroblasts through  the use of a replication-competent avian retroviral vector. Cells
infected with the vector were resistant to infection with avian, as well as human
influenza viruses but susceptible to enveloped RNA  viruses.
Biological costs of and risks associated with genetic engineering
Conventional methods of genetic improvement are rather forgiving in the sense
that they induce gradual changes and provide time for  the breeder to  correct
disturbances in biological equilibria that might be harmful to the animals. Gene
transfer, on the other hand, may induce dramatic, undesirable changes that will
disturb development  or physiological functions  that are  difficult to  correct. However,new technological developments, such as homologous recombination and use of
embryonic stem  cells for gene transfer will likely reduce the risks.
Given  the extent of  work  on  transfer of  disease resistance-inducing genes in both
plants and  animals, surprisingly  little research has  been  done  on  the  possible physio-
logical consequences of adding such new  genes to cells. Consequences of  transgenes
have been demonstrated in plants by Hilder and Gatehouse (1991). They  studied
lines of transgenic tobacco containing a cowpea trypsin inhibitor gene construct
which expressed the transgene at various levels and plants that possessed, but did
not express, the gene. Small, but in some  instances, significant differences between
the transgenic and non-transformed plants were found in various parameters but
there was  no  additional difference between  plants that expressed the transgene and
those that did not. They concluded that although the transformation may have
some  small effects on  non-targeted phenotypic characteristics, the expression of  the
transgene at high levels imposed no additional yield penalty on the plants.
Negative genetic correlations between disease resistance and production traits
have been reported (eg, Gavora, 1990) but their basis as to linkage or pleiotropy
is not clearly established. Design of genetically engineered resistance mechanisms
may have to take possibility of such negative correlations with production traits
into consideration.
As  mentioned  above, a  transgene that successfully induced  resistance of  chickens
to avian leukosis retrovirus subgroup A  in chickens (Salter and Crittenden, 1989)
was shown  to result in a sizeable reduction of egg production rate (Gavora et al,
1995a). It was suggested that the reduced ovulation rate was due to interference
of the viral envelope protein produced by the transgene with the attachment of
the virus to host cells and also with transport of lipids into the developing egg
yolk, since the virus uses an LDL  receptor for entry into host cells  (Bates et  al,
1993). On  the other hand, a transgene containing a gene for a capsid protein of
bovine rotavirus in laboratory mice (Gavora et al,  1994) was not associated with
any significant effects on  their growth and reproductive performance (J Nagai and
JS Gavora, unpublished  results). Hence,  significant ’biological costs’ may  not always
accompany  insertion of transgenes but they need to be considered in strategies for
genetic engineering of new  resistance mechanisms.
Reports on work on assessment of risks involved in the production of varieties
with  new, genetically engineered resistance are only available for plants. Transgenic
plants expressing  viral pathogen-derived DNA  sequences have been  considered sites
for hyperevolution of viruses through recombination of a mild or defective viral
genome  with the transgene (De Zoetten, 1991). However, there is no experimental
evidence to confirm this supposition. On  the contrary, evidence against this type of
event exists through  one  to up  to eight viral passages, even though  heteroincapsida-
tion of  viral RNA  by  transgenically expressed viral coat proteins has been  observed
(Wilson, 1993).
The danger that transgenic crops may generate new viruses and diseases has
been assessed by Falk and Bruening (1994). They provide evidence that genomic
recombination was observed when  transgenic tobacco plants expressing a segment
of cowpea chlorotic mottle virus genomic RNA  were inoculated with a mutant
of the same virus  that  contained  a  deletion  (Greene and Allison,  1994).  The
important question  is  whether such recombination can produce dangerous newviruses. RNA-RNA  recombination has indeed been demonstrated for four groups
of RNA  plant  viruses.  The recombination occurs between closely related RNA
molecules, possibly at sites of  similar RNA  structure. Under  usual crop production
circumstances, opportunities exist for genetic interaction between plant viruses in
mixed  virus infections. Since both  crop plants and weeds may  be present in a  field,
recombinations between  a  virus that cannot infect a  plant and  one  that can, do  not
have a zero probability. Nevertheless, mixed infections rarely result in new plant
pathogenic viruses. Instead, new  viral diseases are usually due to minor variants
of already known viruses.  Generally, however, existing viruses are stable, having
to fit hosts that evolve only slowly. Falk and Bruening (1994) believe it  is unlikely
that recombinations between transgene RNA  and viral genomic RNA  will occur
at greater frequencies than the recombinations already occurring between virus
genomic RNAs  in natural infections.
In the past, development of resistant plants by  traditional breeding fostered the
emergence of virulent virus strains (Dawson and Hilf,  1992) but the cost of this
phenomenon is much less than the cost of abandoning plant breeding. Similarly,
the benefits of engineered plant resistance genes far outweigh the vanishingly small
risk of creating harmful new  viruses in significant excess over those being created
by natural processes (Falk and Bruening, 1994).
In mice, endogenous proviruses are known to recombine with exogenous viral
sequences to give rise to novel viruses with unique properties (Pincus et al,  1992).
Similar recombinants between exogenous and endogenous avian retroviruses had
been  produced  in vitro and  used  as transgenes to induce  resistance to the exogenous
retrovirus in chickens (Salter and Crittenden, 1989).
Endogenous  viral genes may  be regarded as prototypes of  transgenes in animals.
Early evidence  that  Rous sarcoma virus  recombined with envelope protein  of
endogenous avian virus was provided by Hanafusa et al  (1970). Recently, an env
gene related to endogenous viral gene was found on the exogenous avian leukosis
virus subgroup J (Bai et al,  1995). There is also evidence that the alv6 transgene
that expresses the avian leukosis virus subgroup A  envelope can recombine with
endogenous virus  from gene  ev21 to produce subgroup A infectious  virus  (LB
Crittenden, personal communication).
Until more  results become  available in animals, we  could assume  that a  situation
similar to that described above for plants will also exist in livestock. However, it is
imperative  to keep the  possible risks in mind  in designing  strategies for induction of
resistance by  genetic engineering and  to experimentally assess the recombinations,
if any, between transgenes and existing viruses in farm animals and birds.
An example of an increase  in the virulence of an animal virus that may be
associated with improved resistance of the host by vaccination and genetic means
is  the  emergence of  highly  virulent  Marek’s  disease  herpesviruses  in  chickens
(Witter, 1988). The  viruses may  have emerged as a consequence of  vaccination and
conventional selection for resistance that included efforts to increase the frequency
of major histocompatibility haplotypes associated with such resistance. Genetically
engineered resistance may provide a more stable solution to the Marek’s disease
problem.  Conventional breeding and vaccination improved survival  of chickens
infected by Marek’s disease virus. However, the virus continues to be present in
vaccinated birds so there are ample opportunities for its mutations towards highervirulence. A  genetically engineered mechanism  that would prevent the entry of the
virus  into  the  host  cells would  reduce  the  size of  the  viral population  and  thus  reduce
the possibility of such viral evolution. Unfortunately emergence of  viral mutations
to overcome the genetically engineered barrier to virus entry would be difficult to
eliminate.
It  seems that  the arguments used by plant  breeders in  favor  of continuing
research toward new, engineered resistance genes should also be  valid for livestock.
A  necessary prerequisite for  this development has to be an adequate system of
controls and thorough testing of the engineered livestock.
PREREQUISITES AND  STRATEGIES FOR  GENETIC
ENGINEERING  OF  DISEASE  RESISTANCE  IN LIVESTOCK
As mentioned above, any introduction of new genetic material into a cell carries
with it  a risk of disrupting cell functions. This risk has to be kept in mind  in the
design of new  resistance mechanisms. It may  be possible to minimize such risks on
the basis of a thorough understanding of the physiology of virus-infected animals
and interactions between  the virus and  the host.
Another, no less important aspect of the design of new resistance mechanisms
is  their long-term stability. The new mechanism may become ineffective through
evolution of  the virus which  will overcome  the resistance provided by  the  transgene.
Evolution  of  pathogen  virulence genes that overcame  resistance induced by  conven-
tional breeding  is well known  and documented  in plants (Flor, 1956; Wilson, 1993),
and a possible instance of a similar phenomenon observed with Marek’s disease
herpesvirus in chickens was mentioned above.
The  design of new mechanisms and strategies of disease resistance to be intro-
duced into livestock by genetic engineering techniques is  a search for mechanisms
that did not, for whatever reason, develop by evolution. Unlike most of the mech-
anisms of defence of the hosts against viruses that resulted in virus tolerance by
the host, the ideal goal of the new, engineered mechanisms should be prevention
of viral entry into host cells. It may  be easier to develop new  resistance strategies
for viruses which depend for most of  their functions on  the host cell than  for those
that provide for the functions in their genome. New  techniques of molecular and
cell biology allow transfers of genes between species, taxonomic genera and even
kingdoms  so  that we  are no  longer  limited by  the  constraints of  sexual  compatibility.
Recent progress in the development of techniques of homologous recombination,
together with the  use  of embryonic stem cells  for  gene transfer  provide good
prospects for progress in this area of research (First et  al,  1994). While the use
of both of these techniques is  now routine in laboratory mice, their application
in animal agriculture is hampered by the unavailability of a reliable technique for
the production  of  embryonic stem  cells in any  of the livestock species. Nevertheless,
given  the  high  level of  interest and  scientific activity in this area  in several countries,
it is likely only a matter of time before embryonic stem cells will become  available
for introduction of new  genetic information into the genomes of farm animals and
birds.
Homologous recombination and use of embryonic stem cells will allow insertion
of a transgene in a predetermined location in the genome. In the case of geneconstructs designed  to induce new  resistance mechanisms,  the  insertion  will likely be
targeted into a  ’neutral’ region of the genome, to minimize the potential disruption
of important genomic  functions. After successful insertion, it will be  possible to test
the transformed embryonic  stem  cells in culture for the expression of  the transgene,
its stability and, as much  as possible, its undesirable  effects on  the  cells. Preliminary
testing in cell culture for resistance to the pathogen  in question  will be  also possible.
Only the embryonic cell lines that will meet criteria of acceptability in the above
tests will be used for the introduction into developing embryos with the goal of
producing  disease  resistant transgenic  individuals. It is anticipated  that  the  protocol
will make the introduction of new disease resistance mechanisms into livestock
less expensive. The approach will also be less risky as the dangers of disruption
of important genetic mechanisms by the transgene insertion will be reduced by
gene targeting. Moreover, the reduction of such risks will make the research more
acceptable for both livestock producers and the general public. Unfortunately, the
use of advanced techniques of gene transfer  will  likely  be limited to developed
countries.
Because of their relative simplicity and small size,  the genomes of viruses are
generally better understood  than  those of host cells. Many  viral genomes  have been
sequenced and it  is  generally easy to obtain the necessary sequence information
for viral genes that are candidates for inclusion into potential resistance-inducing
transgene constructs.
The general principles  for  the design of new resistance mechanisms and the
new defence strategies can be summarized as follows. The most useful would be
mechanisms based on an element common  to the life cycle of multiple viruses thus
inducing resistance simultaneously to more than one virus. The new mechanisms
should be designed to minimize their biological and financial costs. Targeting of
transgenes into  ’neutral’  regions of the genome may be one such strategy.  The
’neutrality’ of such regions can be tested by inserts of non-functional genes. The
regions proven to be ’neutral’ would be subsequently used for inserts of resistance
genes. Ideally the functioning of the new mechanisms should be triggered by the
presence  of  the  inducing  virus, otherwise  the mechanism  should  remain  ’silent’. This
type of mechanism would minimize its biological cost to the host.
Despite preliminary testing of transformed cells in culture,  it  will be essential
to subject livestock carrying the resistance transgenes to a series of rigorous tests
(Smith  et al, 1987; Gama  et al,  1992). The  tests need  to prove the genetic potential
of the new stock for economically important production traits,  general viability,
as well as resistance against the disease for which the transgene was designed.
In instances of slight  impairment of the production capacity of the transgenic,
compared  to the  original stock, decisions on  the practical usefulness of the modified
animals  will  depend on comparison of the economic benefit  derived  from the
transgene against the cost of the animals’ reduced production performance. In this
context, the prevalence of the pathogen in question and the damage it  causes in
the production areas for which  the  resistant animals are intended  will be, no  doubt,
important considerations.
Based on considerations of the viral life cycle, and natural and  genetically engi-
neered resistance mechanisms that were already tested, several possible strategies
can be proposed and are listed below according to stages of viral life  cycle. Thestrategies are identified in a general manner, without reference to specific viruses.
Therefore, no  description  of  details of  their design  and  implementation  is attempted.
The  aim  of  this list is to stimulate further activity in this area by  outlining the op-
portunities that exist. Without a doubt, a new resistance mechanism that would
prevent viral attachment and  penetration into host cells represents the most desir-
able approach. Those acting on subsequent phases of viral life cycle are less desir-
able and  should be considered if prevention of viral attachment and penetration is
impossible.
Viral attachment and  penetration into host cell
Transgenes that
- produce  viral antireceptor (virion surface) proteins to block cellular receptors;
- produce soluble receptors or their components to block virion surface proteins
and  prevent their interaction with cellular receptors;
- replace  host  receptor genes by a modified form that  is  able  to perform the
receptor’s physiological function but does not allow the attachment of the virus;
- produce substances that interfere with viral penetration into host cells.
Multiplication of the virus and  release of its progeny
Transgenes that
- induce antisense RNA  to a part of the viral genome crucial for  virus multi-
plication;
- cause multiplication and accumulation of viral or modified viral RNA  in host
cells;
- disturb viral replicase or its function;
- produce ribozymes attacking viral RNA;
- produce a defective viral protein that competes with the normal one to produce
a high proportion of non-infectious virions.
Viral latency
Transgenes that
- induce and  maintain a latent state of the virus;
- do not allow activation of a virus from its natural latent state.
Spread of virus through the host’s body
Transgenes that
- protect against perturbances of the host’s immune  system;
- produce  the vaccinating antigen only after the immune  system  is fully developed
(self vaccinating transgenes).CONCLUSIONS
Enormous  variability of  viral types in their strategies for life and  survival will likely
make it  difficult to engineer generalized resistance to viruses. In their evolution,
some viruses  have developed strategies  that do not harm the host  sufficiently
to cause extinction of the host - and the virus.  Nevertheless, in some instances
virus-host coevolution has resulted in disease-producing relationships that cause
economic losses  and suffering  of the animals and birds.  Conventional breeding
methods  will remain  the  principal approach  to the improvement  of  disease resistance
in  livestock  but  in  some instances,  introduction of new genetically  engineered
resistance mechanisms may  be  justified.
Prerequisites for the design of new resistance mechanisms include good know-
ledge of the viral genome and life  cycle  (keeping to a minimum the biological
cost of the new strategies to the host) and of the probability that the strategies
will be overcome by viral evolution. A  combination of gene targeting techniques
with embryonic stem cells,  when such cells  become available  for  livestock,  will
greatly facilitate the introduction of new, genetically engineered virus resistance.
All livestock with new  resistance mechanisms  will have  to be  subjected  to thorough
testing. There are several possible strategies for the development of new  resistance
mechanisms in livestock.  The transgenes to be designed for such strategies can
act at various phases in the viral life  cycle.  Ideally, expression of the transgenes
should be triggered by the presence of the inducing virus, otherwise the resistance
mechanism should remain ’silent’.  Strategies that prevent viral entry to the host
are expected to be most valuable as they could eliminate all damage to the host
caused by the virus.
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